Cotosudil

CAS No. 1258833-31-6

Cotosudil( —— )

Catalog No. M35056 CAS No. 1258833-31-6

Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 161 Get Quote
5MG 250 Get Quote
10MG 376 Get Quote
25MG 625 Get Quote
50MG 882 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cotosudil
  • Note
    Research use only, not for human use.
  • Brief Description
    Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.
  • Description
    Cotosudil is a ROCK kinase inhibitor, which can be used for glaucoma or ocular hypertension research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    ROCK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1258833-31-6
  • Formula Weight
    319.42
  • Molecular Formula
    C16H21N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (156.53 mM; Ultrasonic (<60°C)
  • SMILES
    C[C@@H]1CNCCCCN1S(=O)(=O)c1ccc2cnccc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. IYoshihiro Inoue, et al. Prophylactic or therapeutic agent for glaucoma or ocular hypertension. JP2013035802A.
molnova catalog
related products
  • Verosudil

    Verosudil (AR-12286) is a potent ROCK inhibitor (Ki=0.2 nM) that effectively lowers intraocular pressure (IOP) in animal models and human subjects.

  • CAY10746

    CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.

  • Zelasudil

    Zelasudil (RXC007) is a Rho-related (ROCK) kinase inhibitor for the study of idiopathic pulmonary fibrosis and inflammation.